Massachusetts H1080 prohibits insurers from reducing coverage of branded drugs if an FDA-approved equivalent drug is available.

Massachusetts H1080 amends existing law to ensure that insurers cannot discontinue or reduce coverage of a branded drug if an FDA-approved equivalent drug is available. Insurers must maintain coverage until the equivalent drug has been available for at least three months in the commonwealth. The Department of Public Health will determine availability based on factors such as the number of pharmacies carrying the drug, supply levels, and patient access barriers. The bill aims to protect patients' access to necessary medications without immediate disruption.

Massachusetts H1080 prohibits insurers from reducing coverage of branded drugs if an FDA-approved equivalent drug is available.

Massachusetts H1080 amends existing law to ensure that insurers cannot discontinue or reduce coverage of a branded drug if an FDA-approved equivalent drug is available. Insurers must maintain coverage until the equivalent drug has been available for at least three months in the commonwealth. The Department of Public Health will determine availability based on factors such as the number of pharmacies carrying the drug, supply levels, and patient access barriers. The bill aims to protect patients' access to necessary medications without immediate disruption.